| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Appropriate feeding balances risk and quality of life
|
Burki, Talha
|
|
2010
|
11 |
2 |
p. 117-
1 p.
|
artikel
|
| 2 |
Cancer survival in Africa, Asia, and Central America: a population-based study
|
Sankaranarayanan, Rengaswamy
|
|
2010
|
11 |
2 |
p. 165-173
9 p.
|
artikel
|
| 3 |
Cancer survival in the developing world
|
Coleman, Michel P
|
|
2010
|
11 |
2 |
p. 110-111
2 p.
|
artikel
|
| 4 |
Drinking ourselves into oblivion?
|
The Lancet Oncology,
|
|
2010
|
11 |
2 |
p. 103-
1 p.
|
artikel
|
| 5 |
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial
|
Irani, Jacques
|
|
2010
|
11 |
2 |
p. 147-154
8 p.
|
artikel
|
| 6 |
Ewing's sarcoma
|
Balamuth, Naomi J
|
|
2010
|
11 |
2 |
p. 184-192
9 p.
|
artikel
|
| 7 |
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
|
Mitsudomi, Tetsuya
|
|
2010
|
11 |
2 |
p. 121-128
8 p.
|
artikel
|
| 8 |
Histological subtype of gastric cancer in Japan
|
Shitara, Kohei
|
|
2010
|
11 |
2 |
p. 115-116
2 p.
|
artikel
|
| 9 |
Hot flushes: mostly sex neutral?
|
Loprinzi, Charles L
|
|
2010
|
11 |
2 |
p. 107-108
2 p.
|
artikel
|
| 10 |
IGF-1R targeted treatment of sarcoma
|
Toretsky, Jeffrey A
|
|
2010
|
11 |
2 |
p. 105-106
2 p.
|
artikel
|
| 11 |
Immunity unleashed in melanoma
|
Erdmann, Michael K
|
|
2010
|
11 |
2 |
p. 108-109
2 p.
|
artikel
|
| 12 |
Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study
|
Wolchok, Jedd D
|
|
2010
|
11 |
2 |
p. 155-164
10 p.
|
artikel
|
| 13 |
Ki67 in breast cancer: prognostic and predictive potential
|
Yerushalmi, Rinat
|
|
2010
|
11 |
2 |
p. 174-183
10 p.
|
artikel
|
| 14 |
Know thy enemy
|
Burki, Talha
|
|
2010
|
11 |
2 |
p. 120-
1 p.
|
artikel
|
| 15 |
Lateral pelvic lymph-node dissection: still an option for cure
|
Yano, Hideaki
|
|
2010
|
11 |
2 |
p. 114-
1 p.
|
artikel
|
| 16 |
Lateral pelvic lymph-node dissection: still an option for cure – Authors' reply
|
Georgiou, Panagiotis
|
|
2010
|
11 |
2 |
p. 114-115
2 p.
|
artikel
|
| 17 |
Patient access schemes for high-cost cancer medicines
|
Williamson, Steve
|
|
2010
|
11 |
2 |
p. 111-112
2 p.
|
artikel
|
| 18 |
Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis
|
Ueda, Tetsuya
|
|
2010
|
11 |
2 |
p. 136-146
11 p.
|
artikel
|
| 19 |
Resection of colorectal liver metastases: only for younger patients?
|
Power, Derek G
|
|
2010
|
11 |
2 |
p. 116-
1 p.
|
artikel
|
| 20 |
Risk of bleeding not increased by sorafenib or sunitinib
|
Minor, David R
|
|
2010
|
11 |
2 |
p. 112-113
2 p.
|
artikel
|
| 21 |
Risk of bleeding not increased by sorafenib or sunitinib – Authors' reply
|
Je, Youjin
|
|
2010
|
11 |
2 |
p. 113-
1 p.
|
artikel
|
| 22 |
Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study
|
Olmos, David
|
|
2010
|
11 |
2 |
p. 129-135
7 p.
|
artikel
|
| 23 |
Targeting the target: a step forward for the treatment of non-small-cell lung cancer
|
Douillard, Jean Yves
|
|
2010
|
11 |
2 |
p. 104-105
2 p.
|
artikel
|
| 24 |
Teleoncology: current and future applications for improving cancer care globally
|
Hazin, Ribhi
|
|
2010
|
11 |
2 |
p. 204-210
7 p.
|
artikel
|
| 25 |
The metabolic syndrome in cancer survivors
|
de Haas, Esther C
|
|
2010
|
11 |
2 |
p. 193-203
11 p.
|
artikel
|
| 26 |
The sum is greater than the parts
|
The Lancet Oncology,
|
|
2010
|
11 |
2 |
p. 103-
1 p.
|
artikel
|
| 27 |
Using microRNAs to understand cancer biology
|
Weidhaas, Joanne
|
|
2010
|
11 |
2 |
p. 106-107
2 p.
|
artikel
|
| 28 |
US oncologists fight further cuts to Medicare reimbursement
|
Nierengarten, Mary Beth
|
|
2010
|
11 |
2 |
p. 119-
1 p.
|
artikel
|
| 29 |
US secrecy obscures identities of carcinogenic chemicals
|
Furlow, Bryant
|
|
2010
|
11 |
2 |
p. 118-119
2 p.
|
artikel
|
Tijdschrift beschrijving